These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Action of lipotropic factors in experimental cholesterol arteriosclerosis in rabbits. III. Action of methionine]. MARSICO F; DE FAZIO V Riv Ist Sieroter Ital; 1950; 25(2):125-30. PubMed ID: 14776452 [No Abstract] [Full Text] [Related]
26. Studies on myoinositol. 3. On the growth promoting and lipotropic action of some fatty acid esters of myoinositol. Kotaki A; Yagi K J Vitaminol (Kyoto); 1966 Jun; 12(2):169-78. PubMed ID: 4162590 [No Abstract] [Full Text] [Related]
27. [The action of the lipotropic factors in experimental cholesterol arteriosclerosis in the rabbit]. DE FAZIO V; MARSICO F Riv Ist Sieroter Ital; 1950; 25(1):45-51. PubMed ID: 24537703 [No Abstract] [Full Text] [Related]
28. The effect of massive doses of myo-inositol on hepatic phospholipid metabolism. Yagi K; Kotaki A Ann N Y Acad Sci; 1969 Oct; 165(2):710-25. PubMed ID: 4186706 [No Abstract] [Full Text] [Related]
29. [Action of lipotropic factors in experimental cholesterol arteriosclerosis in rabbits. II. Action of anti-fatty liver factor]. DE FAZIO V; MARSICO F Riv Ist Sieroter Ital; 1950; 25(2):118-24. PubMed ID: 14776451 [No Abstract] [Full Text] [Related]
30. [New data in hepato-biliary therapeutics; lipotropic substances and synthetic cholagogues]. GAUDIN MO Deltion Iatrocheirourgike Hetaireia Athenon; 1953; 2():171-6. PubMed ID: 13127427 [No Abstract] [Full Text] [Related]
31. [Use of lipotropic substances in alcoholism; clinical and psychological research]. KOS M; KRAULAND-STEINBEREITHNER F Wien Med Wochenschr; 1956 Feb; 106(8):172-5. PubMed ID: 13312327 [No Abstract] [Full Text] [Related]
33. Clinical experience with parenteral heparin-lipotropic therapy in cardiovascular disease; a preliminary report. READ JT; OBETZ RC Ohio State Med J; 1955 Mar; 51(3):221-5. PubMed ID: 14356684 [No Abstract] [Full Text] [Related]
34. [Lipotropic action of vitamine E and cystine, methionine, inosit and invert sugar on the rat poisoned with carbon tetrachloride]. HARTMANN F; HERTEL R; SCHULZE G; WELLMER H Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1952; 214(2):152-7. PubMed ID: 14953218 [No Abstract] [Full Text] [Related]
35. Arteriosclerosis; a review of the problem with special reference to lipotropic substances. HAYES ER Bull Univ Minn Hosp Minn Med Found; 1948 Jun; 19(29):476-81. PubMed ID: 18862214 [No Abstract] [Full Text] [Related]
36. [PROBLEMS IN DRUG THERAPY AND ATHEROSCLEROSIS PREVENTION]. LUKOMSKII PE Ter Arkh; 1963 Sep; 35():3-13. PubMed ID: 14097108 [No Abstract] [Full Text] [Related]
37. Studies of the effect of lipotropic agents in experimental cholesterol atherosclerosis in the rabbit. BROUN GO; ANDREWS KR; CORCORAN PJ Am Heart J; 1948 May; 35(5):862. PubMed ID: 18912347 [No Abstract] [Full Text] [Related]
38. [DRUGS LOWERING THE CHOLESTEROL LEVEL IN THE BLOOD]. MARKIEWICZ M Pol Tyg Lek; 1963 Sep; 18():1412-6. PubMed ID: 14087059 [No Abstract] [Full Text] [Related]
39. Diabetic retinopathies, effect of lipotropic substances (lipotriad) in treatment. HILGARTNER HL Tex State J Med; 1955 Nov; 51(11):735-7. PubMed ID: 13274349 [No Abstract] [Full Text] [Related]
40. Diet and lipotropic agents in arteriosclerosis. DAVIDSON JD Am J Med; 1951 Dec; 11(6):736-48. PubMed ID: 14902844 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]